Newsfeeds - Spark Newswire

1 minute read

AcelRx Pharmaceuticals Q2 EPS $(0.08), Inline, Sales $400.00K Miss $1.81M Estimate

Today, 7:52 AM

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of

ACRX

8 minute read

Earnings Scheduled For August 16, 2021

By Benzinga Insights

Today, 7:52 AM

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.

ACRX

6 minute read

Uncategorized

Earnings Scheduled For May 17, 2021

By Benzinga Insights

Today, 7:52 AM

Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter.

ACRX

2 minute read

Uncategorized

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

By Shanthi Rexaline

Today, 7:52 AM

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.

ACRX

Latest news

AcelRx Pharmaceuticals Q2 EPS $(0.08), Inline, Sales $400.00K Miss $1.81M Estimate

Earnings Scheduled For August 16, 2021

Earnings Scheduled For May 17, 2021

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off